Evidence map›Paper›PMID 20511233›Full record

ArticleThe Journal of biological chemistry2010

Nitric-oxide dioxygenase function of human cytoglobin with cellular reductants and in rat hepatocytes.

Anne M Gardner, Matthew R Cook, Paul R Gardner

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 95 citations in OpenAlex.

  1. Cytochrome bFree radical biology & medicine · 2026
    Article
  2. CytochromebioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Insights into the function of cytoglobin.Biochemical Society transactions · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Redox-Regulation of α-Globin in Vascular Physiology.Antioxidants (Basel, Switzerland) · 2022
    Article
  14. Cytoglobin has potent superoxide dismutase function.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anne M GardnerCincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Matthew R Cook
Paul R Gardner
University of Dayton · USCincinnati Children's Hospital Medical Center · US

Funding

Flavohemoglobin-catalyzed nitric oxide dioxygenationR01GM065090 · NIGMS · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI GARDNER, PAUL R · 2001 to 2005
$952k
NIGMS NIH HHS GM65090NIGMS NIH HHS R01 GM065090
6 · The paper itself

Abstract

Cytoglobin (Cygb) was investigated for its capacity to function as a NO dioxygenase (NOD) in vitro and in hepatocytes. Ascorbate and cytochrome b(5) were found to support a high NOD activity. Cygb-NOD activity shows respective K(m) values for ascorbate, cytochrome b(5), NO, and O(2) of 0.25 mm, 0.3 microm, 40 nm, and approximately 20 microm and achieves a k(cat) of 0.5 s(-1). Ascorbate and cytochrome b(5) reduce the oxidized Cygb-NOD intermediate with apparent second order rate constants of 1000 m(-1) s(-1) and 3 x 10(6) m(-1) s(-1), respectively. In rat hepatocytes engineered to express human Cygb, Cygb-NOD activity shows a similar k(cat) of 1.2 s(-1), a K(m)(NO) of 40 nm, and a k(cat)/K(m)(NO) (k'(NOD)) value of 3 x 10(7) m(-1) s(-1), demonstrating the efficiency of catalysis. NO inhibits the activity at [NO]/[O(2)] ratios >1:500 and limits catalytic turnover. The activity is competitively inhibited by CO, is slowly inactivated by cyanide, and is distinct from the microsomal NOD activity. Cygb-NOD provides protection to the NO-sensitive aconitase. The results define the NOD function of Cygb and demonstrate roles for ascorbate and cytochrome b(5) as reductants.

Indexed as

AnimalsAscorbic AcidCaco-2 CellsCatalysisCell Line, TumorCytochromes b5CytoglobinGlobinsHemeHepatocytesHumansKineticsNerve Tissue ProteinsNeuroglobinNitric OxideOxygenasesAscorbic AcidCYGB protein, humanCygb protein, ratCytochromes b5CytoglobinGlobinsHemeNerve Tissue ProteinsNeuroglobinNitric Oxidenitric oxide dioxygenaseOxygenases

Identifiers

PMID20511233
PMCPMC2911317
OpenAlexW2078025686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.